Effectiveness of nirmatrelvir–ritonavir in preventing hospital admissions and deaths in people with COVID-19: a cohort study in a large US health-care systemJoseph A. Lewnard, Sara Y. Tartof, Laura Puzniak et al.|The Lancet Infectious Diseases|2023Cited by 130